Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation

被引:21
|
作者
Chegounchi M. [1 ]
Hanna M.G. [2 ]
Neild G.H. [1 ]
机构
[1] Department of Nephrology, UCL Hospitals Trust, Middlesex Hospital, W1T 3AA, London
[2] Department of Neurology, UCL Hospitals Trust, Middlesex Hospital, W1T 3AA, London
关键词
Tacrolimus; Calcineurin Inhibitor; Tacrolimus Concentration; Slur Speech; Hypertensive Encephalopathy;
D O I
10.1186/1471-2369-7-7
中图分类号
学科分类号
摘要
Background: Tacrolimus and cyclosporine, both calcineurin inhibitors, can cause neurological side effects. While mild symptoms such as tremor are well recognised, severe complications including seizures and encephalopathy are poorly documented following renal transplantation. Case presentation: We report a 42 year old man who received a cadaver renal transplant. He received tacrolimus and prednisolone. The course was uneventful for 6 weeks when he became intermittently confused, with unsteady gait and slurred speech. Following a grand mal convulsion he was admitted. He had no focal neurological signs, cerebrospinal fluid was normal; electroencephalogram was consistent with temporal lobe partial epilepsy. The magnetic resonance imaging of brain showed widespread changes with multiple areas of low signal intensity in brain stem and cerebral hemispheres. He was readmitted 3 weeks later after further fits, despite anti-convulsant therapy. He was psychotic with visual hallucinations, and rapidly became obtunded. Although his tacrolimus blood concentration had been kept in the normal range, his symptoms improved dramatically when the tacrolimus was stopped. Conclusion: Severe central nervous system toxicity from calcineurin inhibitors has been rarely reported in renal transplantation and we found only one report of tacrolimus-induced toxicity in an adult. We believe the condition is frequently undiagnosed. It is a very important diagnosis not to miss as the remedy is simple and failure may result in unnecessary brain biopsy, as well as irreversible injury. © 2006Chegounchi et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [32] Hepatic mucormycosis in a renal transplant recipient: A rare presentation
    Gali, Sai Chandana
    Rukmangadha, N.
    Prayaga, Aruna
    Kumar, V. Siva
    INDIAN JOURNAL OF TRANSPLANTATION, 2019, 13 (01) : 38 - 41
  • [33] Cardiovascular disease and the renal transplant recipient
    Kendrick, E
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) : S36 - S43
  • [34] Graves' disease in a renal transplant recipient
    Suher, M
    Koc, E
    Ensari, C
    Oztugut, SU
    JOURNAL OF NEPHROLOGY, 2004, 17 (05) : 736 - 738
  • [35] The Case | Hypercalcemia in a renal transplant recipient
    Dubrofsky, Lisa
    Lipman, Mark L.
    Nessim, Sharon J.
    KIDNEY INTERNATIONAL, 2015, 88 (05) : 1207 - 1208
  • [36] TACROLIMUS-INDUCED INTERSTITIAL LUNG DISEASE IN A RENAL TRANSPLANT PATIENT
    Correa, Sophia
    Chen, Charles
    Garland, Mateo
    George, Jason C.
    CHEST, 2024, 166 (04) : 3484A - 3485A
  • [37] Epithelial-to-Mesenchymal Transition and Tacrolimus Toxicity in Renal Transplant Recipient
    Bloch, J.
    Glowacki, F.
    Cauffiez, C.
    Buob, D.
    Noel, C.
    Van der Hauwaert, C.
    Hazzan, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 34 - 34
  • [39] Disseminated Strongyloidiasis in Renal Transplant Recipient Complicated with Neurological Manifestations
    Mota, Aline Moreira do Vale
    Silva, Leidiane
    Girao, Evelyne Santana
    Maria, Claudia
    De Oliveira, Costa
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2023, 18 (01):
  • [40] Everolimus-induced Lymphedema in a Renal Transplant Recipient: A Case Report
    Ersoy, Alparslan
    Koca, Nizameddin
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2012, 10 (03) : 296 - 298